Jin Medical International (NASDAQ:ZJYL) Stock Price Up 14.6% – What’s Next?

Jin Medical International Ltd. (NASDAQ:ZJYL – Get Free Report) shares shot up 14.6% during mid-day trading on Monday. The stock traded as high as $3.80 and last traded at $3.8490. 77,889 shares were traded during mid-day trading, a decline of 76% from the average session volume of 331,147 shares. The stock had previously closed at $3.36.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (d)” rating on shares of Jin Medical International in a research report on Friday, September 25th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock has a consensus rating of “Sell”.

Get Our Latest Analysis on Jin Medical International

Jin Medical International Stock Performance

The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.70 and a current ratio of 1.95. The business has a 50 day simple moving average of $2.14 and a 200 day simple moving average of $2.36.

About Jin Medical International

(Get Free Report)

Jin Medical International Limited is a medical device company focused on the design, manufacture and sale of mobility and daily-living assistance products. Through its operating subsidiaries in China, the company serves customers seeking equipment intended to support mobility, personal care and home or institutional use.

The company’s product portfolio includes manual wheelchairs, electric wheelchairs, walking aids and other related medical and rehabilitation equipment. Its offerings are marketed through domestic and international sales channels, serving distributors, retailers and other customers in China and overseas markets.

Jin Medical International is incorporated in the Cayman Islands and conducts its primary operating activities in China.

See Also

Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.